The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference
β Scribed by A. Hatzakis; S. Wait; J. Bruix; M. Buti; M. Carballo; M. Cavaleri; M. Colombo; E. Delarocque-Astagneau; G. Dusheiko; G. Esmat; R. Esteban; D. Goldberg; C. Gore; A. S. F. Lok; M. Manns; P. Marcellin; G. Papatheodoridis; A. Peterle; D. Prati; N. Piorkowsky; M. Rizzetto; F. Roudot-Thoraval; V. Soriano; H. C. Thomas; M. Thursz; D. Valla; P. van Damme; I. K. Veldhuijzen; H. Wedemeyer; L. Wiessing; A. R. Zanetti; H. L. A. Janssen
- Book ID
- 108886637
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 233 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The implication of genotypes is recognized increasingly in the clinical course of hepatitis B virus (HBV) and in response to antiβviral drugs of hepatitis C virus (HCV). Genotypic prevalence of both etiological agents varies geographically and no data are available for Tajikistan. To in
## Abstract Hepatitis B virus (HBV) DNA may persist in the liver in the absence of serum HBVβDNA after a selfβlimited acute hepatitis B. This may also occur in patients with chronic hepatitis C virus (HCV) infection but its prevalence and its impact on liver histology is unknown. HBVβDNA was tested